NAMA
SRTA

Nikko Asset Management Americas’s Strata Critical Medical Inc SRTA Stock Holding History

Nikko Asset Management Americas’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.9M Sell
1,654,361
-23,187
-1% -$112K 0.1% 99
2025
Q4 		$8.05M Sell
1,677,548
-151,073
-8% -$731K 0.09% 95
2025
Q3 		$9.22M Sell
1,828,621
-1,170,571
-39% -$5.17M 0.09% 95
2025
Q2 		$12.1M Hold
2,999,192
– – 0.12% 85
2025
Q1 		$8.16M Sell
2,999,192
-101,481
-3% -$364K 0.11% 88
2024
Q4 		$13.1M Sell
3,100,673
-652,145
-17% -$2.48M 0.14% 79
2024
Q3 		$11M Sell
3,752,818
-284,695
-7% -$906K 0.13% 85
2024
Q2 		$14M Buy
4,037,513
+358,539
+10% +$1.2M 0.16% 77
2024
Q1 		$10.4M Sell
3,678,974
-295,318
-7% -$911K 0.1% 84
2023
Q4 		$14M Sell
3,974,292
-285,969
-7% -$821K 0.13% 78
2023
Q3 		$11M Sell
4,260,261
-264,831
-6% -$930K 0.13% 83
2023
Q2 		$17.7M Sell
4,525,092
-257,547
-5% -$817K 0.19% 73
2023
Q1 		$15.8M Sell
4,782,639
-58,776
-1% -$240K 0.18% 65
2022
Q4 		$17.3M Sell
4,841,415
-32,366
-0.7% -$138K 0.25% 63
2022
Q3 		$19.5M Sell
4,873,781
-53,754
-1% -$276K 0.25% 66
2022
Q2 		$21.4M Buy
4,927,535
+50,669
+1% +$366K 0.26% 63
2022
Q1 		$39M Buy
4,876,866
+544,092
+13% +$3.82M 0.29% 66
2021
Q4 		$38.5M Buy
4,332,774
+1,075,940
+33% +$10.2M 0.2% 80
2021
Q3 		$34.7M Buy
3,256,834
+1,604,814
+97% +$14M 0.15% 85
2021
Q2 		$17.5M Buy
1,652,020
+717,064
+77% +$7.08M 0.07% 104
2021
Q1 		$9.62M Buy
934,956
+919,355
+5,893% +$12.8M 0.05% 139
2020
Q4 		$173K Buy
+15,601
New +$159K ﹤0.01% 212

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nikko Asset Management Americas's SRTA Position: Q1 2026 in Review

Nikko Asset Management Americas reduced its Strata Critical Medical Inc (SRTA) stake by 1.4% in Q1 2026, selling an estimated $112K and leaving 1,654,361 shares worth $6.9M. The position accounts for 0.1% of the portfolio, ranked #99.

Nikko Asset Management Americas first reported a position in SRTA in Q4 2020 and has held it in 22 quarters since. The position peaked at $39M in Q1 2022. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Nikko Asset Management Americas held 1,654,361 shares of Strata Critical Medical Inc worth $6.9M as of Q1 2026.
  • Nikko Asset Management Americas sold 23,187 Strata Critical Medical Inc shares in Q1 2026, an estimated $112K.
  • Strata Critical Medical Inc made up 0.1% of Nikko Asset Management Americas's portfolio in Q1 2026, its #99 holding.
  • Nikko Asset Management Americas first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 22 quarters since.
  • Nikko Asset Management Americas's Strata Critical Medical Inc position peaked at $39M in Q1 2022.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.